Medication-Assisted Treatment (MAT) Frequently Asked Questions
Compliance with HRSA Requirements for Scope of Project, Patient Access and Patient Payments
Year Developed: 2019
Resource Type: Publication.Primary Audience: Administrative Staff
Board of Directors
C-Suite (CEOs, CFOs, CIOs, COOs, CMOs, etc)
Clinicians
PCAs
Secondary Audience: Enabling Staff
Outreach Staff
Language(s): English
Developed by: National Association of Community Health Centers (See other resources developed by this organization).
Resource Summary: In practice, SUD-related services encompass various types of treatments based on the specific addiction disorder. One component is the provision of Medication-Assisted Treatment (MAT) services – a strategy that combines both drug and behavioral therapies to combat substance use disorders, and which may include opioid treatment programs (OTPs) such as Buprenorphine Therapy, non-opioid medication treatments and classes, and various behavioral health therapies. This Frequently Asked Questions (FAQ) document focuses on some of the more common questions related to the application of HCP requirements to the provision of MAT services. In particular, this FAQ addresses questions that often arise regarding the relationship between MAT services and the health center’s overall “scope of project,” patient access within the context of the HCP requirement to offer services to all residents of the service area, and patient payments for MAT services.
Resource Topic: Emerging Issues, Finance
Resource Subtopic: Behavioral Health, Substance Use Disorders.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.